Exercise Reset for Concussion in a Military Environment
NCT ID: NCT05498038
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
168 participants
INTERVENTIONAL
2024-08-07
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Aerobic Exercise for Recovery From Work-related Concussion
NCT06263179
Acute Concussion Therapy Intervention Training in Healthy and Concussed Participants
NCT02872480
Early Sub-threshold Exercise Treatment for Concussion
NCT03569709
The Effect of Exercise on Neurorecovery Following Mild Traumatic Brain Injury
NCT02276079
The Study of Cognitive Rehabilitation Effectiveness for Mild Traumatic Brain Injury
NCT01339806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hyp 1.1: Aerobic exercise+DoD PRA early after injury speeds RTD and improves clinical recovery in CSM compared to the DoD PRA protocol alone. Hyp 1.2: Early aerobic exercise+DoD PRA protects against risk of PPCS in concussed service members (CSM) at 1 and at 3 months post-injury versus the DoD PRA protocol alone.
Aim 2: Determine whether a March-in-place test informs clinical decision-making and contributes to RTD decisions. Hyp 2.1: The degree of early exercise intolerance on the Buffalo Concussion March Test (BCMT) will correlate with the development of PPCS and inform clinician decision making on RTD.
Aim 3: Determine how aerobic exercise improves concussion recovery. Hyp 3.1: Aerobic exercise improves abnormal autonomic nervous system (ANS) regulation in CSM. Hyp 3.2: Aerobic exercise improves expression of salivary brain-derived neurotrophic factor (BDNF), BDNF-related miRNAs, and inflammatory-related miRNAs seen in CSM. Hyp 3.3: Aerobic exercise improves mental health (i.e., anxiety/depressive symptoms, sleep, resilience, self-efficacy, morale) in CSM.
Aim 4: Evaluate the suitability of the Exercise RESET testing and intervention approach for military use informed by study participants and providers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Control Service Members
Non-concussed, age-matched SM will serve as a healthy control group (HC) for comparing CSM to normal physiology and to control for the effect of time and of aerobic exercise. All HC participants will be provided with an activity monitor (with GPS tracking disabled) to wear 24 hours/day for measurement of daily physical activity and sleep duration over the time between first and final test sessions. The activity monitor also acts as an HR monitor to record the participants' HR during their prescribed exercise bouts. HC will be asked to exercise each day at approximately 70% of their age-predicted maximum heart rate (from the formula 220 minus age x 0.7 = target HR) for 20 minutes to control for the effect of exercise on the physiological tests.
No interventions assigned to this group
Concussed Service Members PRA
CSM randomized to PRA alone will receive written instructions on how to follow the PRA protocol. All participants will be provided with an activity monitor (with GPS tracking disabled), and we will record daily physical activity and sleep patterns.
No interventions assigned to this group
Concussed Service Members PRA+Exercise
CSM randomized to aerobic exercise+PRA will receive their individualized aerobic exercise prescription plus written instructions on how to follow the PRA protocol. CSM will start the exercise program the day after the first visit. All participants will be reminded each day by text message to complete their assigned activity (in the case of exercise + PRA participants, to perform their exercise at the prescribed dose \[HR\]) and to report any adverse effects). All participants will also report symptoms once daily in response to a text message to their phone. All participants will wear an activity monitor continuously until clinical recovery or for 4 weeks to measure daily activity and sleep. The activity monitor will also act as an HR monitor and will be worn by participants in the PRA+aerobic exercise group during daily exercise sessions to measure participant adherence to the prescribed exercise dose.
Aerobic Exercise
Participants are asked to complete at least 20 minutes of aerobic exercise every day, excluding clinic visits.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercise
Participants are asked to complete at least 20 minutes of aerobic exercise every day, excluding clinic visits.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active-duty service member
* Aged 18-40 years
* Injury occurred within 9 days of injury
* Diagnosed with concussion by an experienced clinician using standard international criteria
For the HC Group:
* Active-duty service member
* Ages 18-40
* Active duty
* Currently active clinician (MD, DO, PT, ATC, OT) involved in concussion management beyond initial emergent diagnosis
* Willing to participate
* Able to be contacted by telephone or Zoom
Exclusion Criteria
* Moderate or severe TBI as indicated by a GCS score \<13, lesion on CT/MRI, and/or focal neurologic sign consistent with intracerebral lesion
* Injury involving loss of consciousness for \>30 minutes or post-traumatic amnesia \>24 hours
* Inability to exercise because of lower-extremity orthopedic injury, clinically significant vestibular or visual dysfunction, or increased cardiac risk
* Pre-existing conditions that prevent participation in active testing and/or rehabilitation
* Active substance abuse/dependence
* Unwillingness to perform intervention
* Limited English proficiency
* Confirmed pregnancy
For the HC group:
* Has lingering symptoms from a previous concussion or has recovered from a concussion less than 1-month ago
* On a limited profile or "chit" for light duty
* Active substance abuse/dependence
* Unwilling to perform intervention
* Limited English proficiency
* Confirmed pregnancy
* Not active duty
* Not currently an active clinician (MD, DO, PT, ATC, OT) involved in concussion management
* Only involved in concussion management at emergent timepoint
* Unwilling to participate
* Unable to be contacted by telephone or Zoom
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Children's Hospital of Philadelphia
OTHER
University of Pennsylvania
OTHER
University of North Carolina, Chapel Hill
OTHER
The Geneva Foundation
OTHER
Center for Neuroscience and Regenerative Medicine (CNRM)
FED
Axon Medical Technologies LLC
INDUSTRY
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John J. Leddy MD
John J Leddy, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Leddy, MD
Role: PRINCIPAL_INVESTIGATOR
University at Buffalo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fort Liberty
Fayetteville, North Carolina, United States
Camp LeJeune
Jacksonville, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kaleigh Presgraves
Role: primary
Robert Carlson, MPT
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TP210003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.